A Phase 2, Randomized, Double-blind, Placebo-Controlled Efficacy, Pharmacokinetics and Safety Study of CA-008 in Subjects Undergoing Complete Abdominoplasty
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2019
At a glance
- Drugs CA-008 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Concentric Analgesics
- 26 Dec 2018 Status changed from planning to recruiting.
- 22 Nov 2018 New trial record
- 07 Nov 2018 According to a Concentric Analgesics media release, the company plans to immediately initiate this phase II study in surgical model of abdominoplasty.